Phenotype
|
Fish
|
Conditions
|
Figures
|
pancreas prss1 expression decreased distribution, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
intestinal epithelial cell ab4-h3 labeling decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 4
from Ma et al., 2022
|
intestine morphology, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestine has fewer parts of type intestine goblet cell, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 4
from Ma et al., 2022
|
swim bladder uninflated, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|
intestine ab3-map1lc3b labeling decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
intestinal epithelial cell ribosome biogenesis decreased process quality, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
mandibular arch skeleton malformed, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestinal bulb fabp2 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 2
from Ma et al., 2022
|
intestine decreased size, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestine goblet cell decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 4
from Ma et al., 2022
|
intestine fabp2 expression decreased distribution, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
whole organism mdm2 expression increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|
pancreas decreased size, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
exocrine pancreas prss1 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 2
from Ma et al., 2022
|
swim bladder uninflated, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestinal epithelial cell mitochondrion malformed, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
digestive system fabp2 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|
intestine lumen decreased size, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 2
from Ma et al., 2022
|
intestinal epithelial cell nucleus increased size, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 6
from Ma et al., 2022
|
yolk absorption quality, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
pancreas prss1 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
liver decreased size, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
whole organism il1b expression increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
intestine Ab1-mt-co1 labeling spatial pattern, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
pancreas morphology, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
whole organism mmp9 expression increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
intestine fabp2 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
intestinal epithelial cell nucleus ab1-fbl labeling increased distribution, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 6
from Ma et al., 2022
|
intestinal epithelial cell autophagy increased process quality, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
mid intestine fabp6 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 2
from Ma et al., 2022
|
whole organism saa expression increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
intestine Ab1-mt-co1 labeling decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
liver fabp10a expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 2
from Ma et al., 2022
|
liver morphology, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestinal epithelial cell nucleus ab1-fbl labeling increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 6
from Ma et al., 2022
|
digestive system hbae3 expression decreased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|
intestinal epithelial cell nucleoplasm ab1-ncl labeling mislocalised, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 6
from Ma et al., 2022
|
eye decreased size, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
liver increased accumulation liver lipid droplet, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 2
from Ma et al., 2022
|
gut collapsed, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
whole organism curved, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestine ab3-map1lc3b labeling spatial pattern, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
whole organism viability, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestinal epithelial cell nucleoplasm ab1-fbl labeling mislocalised, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 6
from Ma et al., 2022
|
whole organism cxcl8b.1 expression increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
whole organism mmp13a.1 expression increased amount, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
intestinal epithelial cell inflammatory response increased process quality, abnormal
|
ercc2whu312/whu312
|
standard conditions
|
Fig. 5
from Ma et al., 2022
|
liver DsRed expression decreased amount, abnormal
|
ercc2whu312/+; gz15Tg
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
liver DsRed expression decreased distribution, abnormal
|
ercc2whu312/+; gz15Tg
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
pancreas DsRed expression decreased distribution, abnormal
|
ercc2whu312/+; gz15Tg
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
pancreas DsRed expression decreased amount, abnormal
|
ercc2whu312/+; gz15Tg
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
pancreas ela3l expression decreased distribution, abnormal
|
ercc2whu312/whu312; gz15Tg
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
liver DsRed expression decreased amount, abnormal
|
ercc2whu312/whu312; gz15Tg
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
pancreas ela3l expression decreased amount, abnormal
|
ercc2whu312/whu312; gz15Tg
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
liver DsRed expression decreased distribution, abnormal
|
ercc2whu312/whu312; gz15Tg
|
standard conditions
|
Fig. 3
from Ma et al., 2022
|
liver hypoplastic, abnormal
|
ercc2whu312/whu312; gz15Tg
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
exocrine pancreas hypoplastic, abnormal
|
ercc2whu312/whu312; gz15Tg
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestine endocrine cell EGFP expression mislocalised, abnormal
|
ercc2whu312/whu312; ia3Tg
|
standard conditions
|
Fig. 4
from Ma et al., 2022
|
intestine endocrine cell nkx2.2a expression mislocalised, abnormal
|
ercc2whu312/whu312; ia3Tg
|
standard conditions
|
Fig. 4
from Ma et al., 2022
|
intestine EGFP expression spatial pattern, abnormal
|
ercc2whu312/whu312; sqet33J1Et
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestine EGFP expression decreased distribution, abnormal
|
ercc2whu312/whu312; sqet33J1Et
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
gut decreased size, abnormal
|
ercc2whu312/whu312; sqet33J1Et
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
intestine EGFP expression decreased amount, abnormal
|
ercc2whu312/whu312; sqet33J1Et
|
standard conditions
|
Fig. 1
from Ma et al., 2022
|
swim bladder uninflated, abnormal
|
tp53zdf1/zdf1; ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|
digestive system fabp2 expression decreased amount, abnormal
|
tp53zdf1/zdf1; ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|
digestive system hbae3 expression decreased amount, abnormal
|
tp53zdf1/zdf1; ercc2whu312/whu312
|
standard conditions
|
Fig. 7
from Ma et al., 2022
|